Litcius/Paper detail

Folic acid-modified disulfiram/Zn-IRMOF3 nanoparticles for oral cancer therapy by inhibiting ALDH1A1+ cancer stem cells

Jiasen Cui, Weitao Li, Wenhuan Bu, Jinhui Liu, Xi Chen, Xuewen Li, Chunran Liu, Lin Meng, Mingli Chen, Hongchen Sun, Jianhua Wang

2022Biomaterials Advances17 citationsDOI

Topics & Concepts

DisulfiramCancer stem cellCancer researchIn vivoPharmacologyCancer cellCancerDrug deliveryChemistryCancer therapyDrugMedicineNanotechnologyMaterials scienceInternal medicineBiologyBiotechnologyAutophagy in Disease and TherapyHeme Oxygenase-1 and Carbon MonoxideMetal-Organic Frameworks: Synthesis and Applications
Folic acid-modified disulfiram/Zn-IRMOF3 nanoparticles for oral cancer therapy by inhibiting ALDH1A1+ cancer stem cells | Litcius